What is the pathophysiology of ischemic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Ischemic Stroke

Primary Mechanism: Vascular Occlusion and Cerebral Ischemia

Ischemic stroke occurs when blocked blood vessels to the brain lead to cerebral infarction, initiating a cascade of cellular injury that progresses from oxygen deprivation to irreversible neuronal death. 1

The fundamental pathophysiologic sequence begins with arterial occlusion—either thrombotic or embolic—that reduces cerebral blood flow below the threshold needed to maintain neuronal function. 2 This deprivation of glucose and oxygen triggers the ischemic cascade, ultimately resulting in neuronal death and irreversible loss of neuronal function. 3

Mechanisms of Arterial Occlusion

Ischemic stroke arises through four distinct but non-mutually exclusive mechanisms: 1

  • Perfusion failure from stenosis combined with poor collateral circulation, causing hemodynamic insufficiency 1
  • In-situ thrombosis at the stenosis site due to complicated atherosclerotic plaque (rupture, hemorrhage into plaque, or occlusive plaque growth) 1
  • Thromboembolic events distal to the stenosis, where plaque fragments or thrombi embolize downstream 1
  • Direct occlusion of penetrating arteries at the plaque site, particularly relevant in small-vessel disease 1

The Ischemic Cascade: Cellular and Molecular Events

Energy Failure and Excitotoxicity

When cerebral blood flow drops below critical thresholds, ATP depletion occurs within minutes, causing failure of energy-dependent ion pumps. 2 This leads to:

  • Ionic imbalances with massive influx of sodium, chloride, and calcium into cells 3
  • Glutamate release and activation of glutamate receptors (NMDA, AMPA, kainate), triggering excitotoxicity 2, 3
  • Calcium overload that activates destructive enzymes including proteases, lipases, and endonucleases 2

Mitochondrial Dysfunction and Oxidative Stress

Mitochondria serve as both victims and perpetrators in ischemic injury, generating excessive reactive oxygen species (ROS) that amplify cellular damage. 1

During ischemia and particularly during reperfusion, mitochondria become the major source of intracellular ROS. 1 Free electrons leak from the mitochondrial electron transport chain and react with molecular oxygen, generating superoxide anion (O2-). 1 This highly reactive molecule forms peroxynitrite (NO3-) when combined with nitric oxide, ultimately producing cytotoxic hydroxyl radicals that damage DNA, proteins, and lipids. 1

Mitochondrial fission precedes neuronal death after cerebral ischemia, with increased phosphorylation of dynamin-related protein 1 (Drp1) at serine 616 driving this process. 1 Inhibition of Drp1 reduces infarct volume in experimental models. 1

Inflammatory Response

Inflammation amplifies ischemic injury through glial cell activation, peripheral leukocyte infiltration, and release of damage-associated molecules. 1

The outer mitochondrial membrane serves as a platform for NLRP3 inflammasome assembly, which activates innate immune defense and pyroptosis through pro-inflammatory cytokines (particularly IL-1β) and caspase-1. 1 Acute systemic inflammatory stimuli worsen stroke outcomes, with IL-1β acting as a critical mediator. 1

Apoptosis and Cell Death

The ischemic cascade culminates in both necrotic and apoptotic cell death pathways. 3 Mitochondrial dysfunction triggers release of cytochrome c and activation of caspase cascades, leading to programmed cell death in the penumbral region. 2

The Penumbra Concept

A critical fraction of the ischemic territory exists in a "penumbral" state—tissue that is functionally impaired but structurally viable and potentially salvageable. 4

Local tissue fate depends on:

  • Severity of hypoperfusion in the affected vascular territory 4
  • Duration of occlusion before recanalization 4
  • Collateral circulation adequacy 1

The penumbra represents the primary therapeutic target, as this tissue will either recover with reperfusion or progress to infarction without intervention. 4

Blood-Brain Barrier Disruption

Ischemia causes dysfunction of carrier-mediated nutrient and ion transport mechanisms across the blood-brain barrier. 5 Since the brain relies on continuous supply of nutrients via these transport processes, any irregularity dramatically affects neuronal function and stroke outcome. 5 BBB breakdown also permits vasogenic edema and hemorrhagic transformation. 5

Etiologic Subtypes and Their Pathophysiology

The underlying vascular pathology determines the specific ischemic mechanism: 1, 6

  • Large-artery atherosclerosis (20%): Extracranial or intracranial atherosclerotic disease causing artery-to-artery embolism or hemodynamic insufficiency 1, 6
  • Cardioembolism (20%): Intracardiac thrombi (predominantly from atrial fibrillation) embolize to cerebral vessels 1, 6
  • Small-vessel disease (25%): Arteriolosclerosis (lipohyalinosis) of penetrating arteries causes lacunar infarcts ≤1.5 cm 1, 6
  • Cryptogenic (30%): Unknown mechanism despite comprehensive evaluation 1, 6

Clinical Implications

The pathophysiologic heterogeneity from patient to patient is largely unpredictable from elapsed time or clinical deficit alone, necessitating individualized assessment with physiological imaging (DWI-PWI MRI or CT perfusion) to identify salvageable penumbra and guide therapy. 4 Variables like blood pressure, blood glucose, and oxygen saturation must be carefully managed to prevent penumbral tissue from progressing to infarction. 4

The narrow therapeutic window for interventions like thrombolysis (3-4.5 hours) and thrombectomy (6 hours) reflects the time-dependent progression of the ischemic cascade from reversible injury to irreversible infarction. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis.

Pathophysiology : the official journal of the International Society for Pathophysiology, 2010

Guideline

Ischemic Stroke Etiology and Procedural Stroke Risks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.